ADRENOMED
Adrenomed is a privately-financed, clinical-stage biopharmaceutical company with a clear mission: to rescue vascular integrity in order to save the lives of critically ill patients with limited treatment options. The Company’s lead product candidate is Adrecizumab, a clinical-stage, first-in-class monoclonal antibody. Adrecizumab targets the vasoprotective peptide Adrenomedullin, an essential regulator of vascular integrity to treat life-threatening conditions associated with increased vascul... ar leakage, congestion and shock. their unique treatment approach combines the therapeutic antibody with a specific diagnostic, which uses Adrenomedullin as the biomarker to identify patients. The most important target indications are sepsis and septic shock as well as acute heart failure. Adrenomed’s business is effectively secured by a strong IP position with granted patents in all major markets. Adrenomed is based in Hennigsdorf near Berlin, Germany.
ADRENOMED
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2009-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.adrenomed.com
Total Employee:
1+
Status:
Active
Contact:
+49 (0) 3302 20 77 8 0
Email Addresses:
[email protected]
Total Funding:
56.83 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Cytovation
Cytovation AS is a privately-held biotech company, specialising .
Exvastat
Exvastat is an innovative, preclinical-stage pharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Halia Therapeutics
Halia is a preclinical-stage biopharmaceutical company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Novaremed AG
Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
Current Employees Featured
Founder
Investors List
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Convertible Note - Adrenomed
HBM Partners
HBM Partners investment in Convertible Note - Adrenomed
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Convertible Note - Adrenomed
Wellington Partners
Wellington Partners investment in Series E - Adrenomed
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series E - Adrenomed
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Convertible Note - Adrenomed
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series D - Adrenomed
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series D - Adrenomed
Wellington Partners
Wellington Partners investment in Series D - Adrenomed
Key Employee Changes
Date | New article |
---|---|
2022-07-12 | Adrenomed appoints David Germonpré as Chief Financial Officer |
2022-06-23 | Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer |
Official Site Inspections
http://www.adrenomed.com
- Host name: 217-160-0-40.elastic-ssl.ui-r.com
- IP address: 217.160.0.40
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin